statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Smith & Nephew (LSE:SN) is a FTSE 100 stalwart. It currently has a market cap of 8.5bn and it's one of the most respected medical device manufacturers around the world. However, things haven't been...

Is this the most undervalued FTSE stock?

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence...

Smith+Nephew's PICO  Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Smith & Nephew introduces RENASYS EDGE NPWT System

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a...

Smith+Nephew introduces the RENASYS  EDGE Negative Pressure Wound Therapy System   an exciting new option in home-based care for patients living with chronic wounds

Smith & Nephew PLC's Dividend Analysis

We consider oversold' to be where one thinks the selling action on said stock has been unduly harsh, presenting a solid buying opportunity in a quality company!
ITV
What it does: Founded in...

5 oversold FTSE stocks to consider buying

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC the world's premier mixed martial...

Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

UFC is an American mixed martial arts promotion company based in Las Vegas, which hosts around 40 fights a year and has more than 700m fans...

Medical supplies firm Smith & Nephew teams up with mixed martial arts promoter the UFC

StockNews.com upgraded shares of Smith  Nephew (NYSE:SNN  Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Friday. Separately, Barclays...

Smith & Nephew (NYSE:SNN) Upgraded to "Strong-Buy" by StockNews.com

Smith  Nephew (NYSE:SNN  Get Free Report) was upgraded by StockNews.com from a buy rating to a strong-buy rating in a research note issued on...

Smith & Nephew (NYSE:SNN) Stock Rating Upgraded by StockNews.com

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Volume	389,367.00
52-Wk High	$33.09
52-Wk Low	$21.53

SNN Smith & Nephew plc

About

Feed

News

Sentiment

Earnings

Fundamentals